These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2659775)

  • 1. Anticonvulsant activities of 1-phenylcyclohexylamine and its conformationally restricted analog 1,1-pentamethylenetetrahydroisoquinoline.
    Rogawski MA; Thurkauf A; Yamaguchi S; Rice KC; Jacobson AE; Mattson MV
    J Pharmacol Exp Ther; 1989 Jun; 249(3):708-12. PubMed ID: 2659775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticonvulsant 1-phenylcycloalkylamines: two analogues with low motor toxicity when orally administered.
    Blake PA; Yamaguchi S; Thurkauf A; Rogawski MA
    Epilepsia; 1992; 33(1):188-94. PubMed ID: 1531130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and anticonvulsant activity of 1-phenylcyclohexylamine analogues.
    Thurkauf A; de Costa B; Yamaguchi S; Mattson MV; Jacobson AE; Rice KC; Rogawski MA
    J Med Chem; 1990 May; 33(5):1452-8. PubMed ID: 2329567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsant activity of the low-affinity uncompetitive N-methyl-D- aspartate antagonist (+-)-5-aminocarbonyl-10,11-dihydro-5H- dibenzo[a,d]cyclohepten-5,10-imine (ADCI): comparison with the structural analogs dizocilpine (MK-801) and carbamazepine.
    Rogawski MA; Yamaguchi S; Jones SM; Rice KC; Thurkauf A; Monn JA
    J Pharmacol Exp Ther; 1991 Oct; 259(1):30-7. PubMed ID: 1920122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticonvulsant activity of novel derivatives of 2- and 3-piperidinecarboxylic acid in mice and rats.
    Hinko CN; Crider AM; Kliem MA; Steinmiller CL; Seo TH; Ho B; Venkatarangan P; el-Assadi AA; Chang H; Burns CM; Tietz EI; Andersen PH; Klitgaard H
    Neuropharmacology; 1996; 35(12):1721-35. PubMed ID: 9076751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
    Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
    Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticonvulsant profiles of the potent and orally active GABA uptake inhibitors SK&F 89976-A and SK&F 100330-A and four prototype antiepileptic drugs in mice and rats.
    Swinyard EA; White HS; Wolf HH; Bondinell WE
    Epilepsia; 1991; 32(4):569-77. PubMed ID: 1831122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of 3-carboxy-5-phosphono-1,2,3,4-tetrahydroisoquinoline (SC-48981), a potent competitive N-methy-D-aspartate (NMDA) receptor antagonist, in vitro and in vivo.
    Vazquez ML; Garland DJ; Sun ET; Cler JA; Mick SJ; Hood WF; Monahan JB; Iyengar S; Rao TS
    Neurosci Lett; 1992 Feb; 135(2):149-52. PubMed ID: 1352628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro.
    Palmer GC; Harris EW; Ray R; Stagnitto ML; Schmiesing RJ
    Arch Int Pharmacodyn Ther; 1992; 317():16-34. PubMed ID: 1456842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist.
    Ferkany JW; Kyle DJ; Willets J; Rzeszotarski WJ; Guzewska ME; Ellenberger SR; Jones SM; Sacaan AI; Snell LD; Borosky S
    J Pharmacol Exp Ther; 1989 Jul; 250(1):100-9. PubMed ID: 2545856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsant properties of calcium channel blockers in mice: N-methyl-D-,L-aspartate- and Bay K 8644-induced convulsions are potently blocked by the dihydropyridines.
    Palmer GC; Stagnitto ML; Ray RK; Knowles MA; Harvey R; Garske GE
    Epilepsia; 1993; 34(2):372-80. PubMed ID: 7681002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects.
    Koek W; Colpaert FC
    J Pharmacol Exp Ther; 1990 Jan; 252(1):349-57. PubMed ID: 2153806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures.
    Rostock A; Tober C; Rundfeldt C; Bartsch R; Engel J; Polymeropoulos EE; Kutscher B; Löscher W; Hönack D; White HS; Wolf HH
    Epilepsy Res; 1996 Apr; 23(3):211-23. PubMed ID: 8739124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization of rat brain phencyclidine receptors in an active binding form that is sensitive to N-methyl-D-aspartate receptor ligands.
    Ambar I; Kloog Y; Sokolovsky M
    J Neurochem; 1988 Jul; 51(1):133-40. PubMed ID: 2898002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral studies on FR115427, a novel selective N-methyl-D-aspartate antagonist.
    Nakanishi H; Katsuta K; Ueda Y; Takasugi H; Kuno A; Ohkubo M; Ogita K; Yoneda Y; Shirakawa K; Yoshida K
    Psychopharmacology (Berl); 1995 Jan; 117(2):172-7. PubMed ID: 7753964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-competitive N-methyl-D-aspartate antagonists protect against sound-induced seizures in DBA/2 mice.
    Chapman AG; Meldrum BS
    Eur J Pharmacol; 1989 Jul; 166(2):201-11. PubMed ID: 2676564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The psychotomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites.
    Rothman RB; Reid AA; Monn JA; Jacobson AE; Rice KC
    Mol Pharmacol; 1989 Dec; 36(6):887-96. PubMed ID: 2557536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phencyclidine analogs and precursors: rotarod and lethal dose studies in the mouse.
    Vaupel DB; McCoun D; Cone EJ
    J Pharmacol Exp Ther; 1984 Jul; 230(1):20-7. PubMed ID: 6747825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist.
    Ferkany JW; Hamilton GS; Patch RJ; Huang Z; Borosky SA; Bednar DL; Jones BE; Zubrowski R; Willetts J; Karbon EW
    J Pharmacol Exp Ther; 1993 Jan; 264(1):256-64. PubMed ID: 8423528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant activity of two orally active competitive N-methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in Papio papio.
    Chapman AG; Graham JL; Patel S; Meldrum BS
    Epilepsia; 1991; 32(4):578-87. PubMed ID: 1678345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.